(PDF) P3.16-07 the Impact of Clinical and Molecular Profile

P3.16-07 the Impact of Clinical and Molecular Profile of Resected EGFR-Mutant Non-Small Cell Lung Cancer on the Risk of Developing Brain Metastases

Journal of Thoracic Oncology - United States

doi 10.1016/j.jtho.2018.08.1914

Full Text

Abstract

Available in full text

Categories

Respiratory Medicine

Date

October 1, 2018

Authors

Publisher

Elsevier BV

Related search

P3.16-29 Prediction of Lymph Node Metastases in Clinical T1aN0M0 Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English

Enhanced Efficacy of AZD3759 and Radiation on Brain Metastasis From EGFR Mutant Non-Small Cell Lung Cancer

International Journal of Cancer

Cancer Research

English

Management of Brain Metastases in Epidermal Growth Factor Receptor Mutant Non-Small-Cell Lung Cancer

Frontiers in Oncology

Cancer Research

English

P3.03-29 the Prognostic Effect of Tumor Mutation Burden and Smoking History in Resected EGFR Mutant Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English

P3.13-07 the Effect of Crizotinib in Patients of Non Small Cell Lung Cancer With Brain Metastases: A Retrospective Analysis

Journal of Thoracic Oncology

Respiratory Medicine

English

Survival of Patients With Non-Small Cell Lung Cancer and Brain Metastases

Clinical Oncology

Nuclear Medicine

English

Non-Small Cell Lung Cancer Brain Metastases and the Immune System: From Brain Metastases Development to Treatment

Cancer Treatment Reviews

Nuclear Medicine

English

Economic Impact of Preventing Brain Metastases With Alectinib in ALK-positive Non-Small Cell Lung Cancer

Cancer Research

Respiratory Medicine

English

P3.01-95 EGFR Genotype as a Predictor of Survival in EGFR Mutant Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English